View drug registration information details.
Items | Registration information |
ID | 271 |
No | 271 |
Brand Name | CARBIROID TABLET 5MG |
Ingredients | CARBIMAZOLE 5 MG |
Dosage Form | TABLET |
Primary Packaging | PVC/ALU - BLISTER |
Storage | STORE BELOW 25C, PROTECT FORM LIGHT |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 5 X 20'S |
Dispensing Category | Prescription only |
ATC Classification | H03BB01 |
Pharmaceutical Class | THYROID DISEASE |
Indications | FOR THE TREATMENT OF HYPERTHYROIDISM, INCLUDING PRIOR TO SURGERY OR RADIOTHERAPY, AS WELL AS CONCOMITANT THERAPY WITH RADIO-IODINE TREAMENT |
Contraindications | BREAST FEEDING |
Side Effects | SKIN RASH, NAUSEA, HEADACHE, GI UPSETS, JOINT PAIN, AGRANULOCYTOSIS |
Unit Price | |
EDL |
No |
Description | ROUND, PINK, UNCOATED TABLET WITH DEEP CONVEX FACES |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | HOVID BHD |
Country | MALAYSIA |
Import Registration No | MAL20142426AEZ |
Import Registration Date | 2019-07-09 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-09-07 |
FDD Registration No | 01 I 5392/23 |
FDD Registration Date | 2023-01-23 |
Expiry Date | 2026-01-22 |
Back to drug list
|